Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Lubrithal** is a Dechra veterinary ophthalmic lubricating gel for dogs and cats. Its active lubricating polymer, carbomer, retains water within the preocular tear film and forms a protective, moisturizing layer over the ocular surface; the gel rapidly liquefies on contact with ocular fluid. It is used to support management of dry-eye disorders, including keratoconjunctivitis sicca, and other settings where ocular surface dryness requires lubrication and protection. The marketed gel contains water, sorbitol, carbomer, sodium hydroxide, cetrimide, and disodium EDTA and is supplied in a 15 g tube. ([dechra.co.uk](https://www.dechra.co.uk/products/dog/non-prescription/lubrithal))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lubrithal.